Newron Pharmaceuticals
NWRN.SW
#8213
Rank
$0.16 B
Marketcap
$8.57
Share price
2.15%
Change (1 day)
56.31%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2023: -$17.91 Million USD

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are $10.01 Million USD. In 2023 the company made an earning of -$17.91 Million USD, an increase over its 2022 earnings that were of -$18.75 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2023

Annual earnings

Year Earnings Change
2023-$17.91 Million-4.45%
2022-$18.75 Million11.19%
2021-$16.86 Million-30.14%
2020-$24.13 Million6.84%
2019-$22.59 Million31.45%
2018-$17.19 Million170.13%
2017-$6.37 Million-60.23%
2016-$16 Million-41.46%
2015-$27.32 Million109.46%
2014-$13.05 Million22.43%
2013-$10.66 Million222.49%
2012-$3.31 Million-60.49%
2011-$8.36 Million-71%
2010-$28.83 Million-17.37%
2009-$34.89 Million52.58%
2008-$22.87 Million41.24%
2007-$16.19 Million-25.19%
2006-$21.65 Million22.45%
2005-$17.68 Million